CGEN
$5.72
Compugen
$.08
1.42%
CGEN
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.11)
Revenue:  N/A
Monday
Feb 10
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, November 11, 2019

What do you expect when CGEN reports earnings?
Beat
Meet
Miss

Where is CGEN's stock price going from here?
Up
Flat
Down
Stock chart of CGEN
Analysts
Summary of analysts' recommendations for CGEN
Score
Grade
Pivots
Resistance
$6.07
$5.93
$5.78

$5.64

Support
$5.49
$5.35
$5.20
Tweet
Growth
Description
Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.